XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of black - scholes option-pricing model valuation assumption

The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

 

 

March 31,

 

2023 (1)

 

2022 (1)

 

2021

Expected volatility

 

NA

 

NA

 

69.18 - 81.11%

Expected term

 

NA

 

NA

 

4.49 - 5.00 Years

Risk-free interest rate

 

NA

 

NA

 

0.32% - 1.39%

Forfeiture Rate

 

NA

 

NA

 

0.0%

 

(1) No stock options were issued for the three months ended March 31, 2023 and the year ended December 31, 2022.

Schedule of outstanding stock options

A summary of the status of the Company’s outstanding stock options as of March 31, 2023 and changes during the periods ending on that date is as follows:

 

 

 

 

 

Weighted Average

 

 

Aggregate

 

 

Weighted

 

 

Shares

 

 

Exercise

 

 

Grant Date
Fair

 

 

Intrinsic
Value

 

 

Average
Remaining

 

 

(000’s)

 

 

Price

 

 

Value

 

 

(000’s)

 

 

Term (Yrs)

 

Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2022

 

 

2,266

 

 

$

9.66

 

 

 

 

 

$

213,914

 

 

 

5.43

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(249

)

 

 

5.11

 

 

 

97.26

 

 

 

22,992

 

 

 

 

Forfeiture and cancelled

 

 

(1

)

 

 

14.53

 

 

 

 

 

 

 

 

 

 

At March 31, 2023

 

 

2,016

 

 

$

10.22

 

 

 

 

 

$

166,829

 

 

 

5.52

 

Exercisable at March 31, 2023

 

 

1,888

 

 

$

8.42

 

 

 

 

 

$

159,544

 

 

 

5.37

 

Schedule of employee stock options outstanding

The following table summarizes information about employee stock options outstanding at March 31, 2023:

 

 

Outstanding Options

 

 

Vested Options

 

Range of Exercise Price

 

Number Outstanding at March 31, 2023 (000's)

 

 

Weighted Average Remaining Life

 

 

Weighted Average Exercise Price

 

 

Number Exercisable at March 31, 2023 (000's)

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Life

 

$0.34 - $1.05

 

 

30

 

 

 

0.58

 

 

$

1.19

 

 

 

30

 

 

$

0.58

 

 

 

1.19

 

$1.97 - $2.95

 

 

5

 

 

 

1.97

 

 

 

2.77

 

 

 

5

 

 

 

1.97

 

 

 

2.77

 

$3.23 - $4.85

 

 

1,389

 

 

 

3.81

 

 

 

5.07

 

 

 

1,389

 

 

 

3.81

 

 

 

5.07

 

$5.59 - $8.38

 

 

214

 

 

 

5.76

 

 

 

5.23

 

 

 

214

 

 

 

5.76

 

 

 

5.23

 

$14.53 - $21.79

 

 

61

 

 

 

14.53

 

 

 

7.34

 

 

 

40

 

 

 

14.53

 

 

 

7.34

 

$21.80 - $32.70

 

 

16

 

 

 

21.80

 

 

 

7.59

 

 

 

10

 

 

 

21.80

 

 

 

7.59

 

$42.64 - $63.96

 

 

301

 

 

 

42.67

 

 

 

7.76

 

 

 

200

 

 

 

42.67

 

 

 

7.76

 

Outstanding options

 

 

2,016

 

 

 

10.22

 

 

$

5.52

 

 

 

1,888

 

 

$

8.42

 

 

 

5.37

 

 

Schedule of restricted stock activity

A summary of the Company’s restricted stock award activity for the three months ended March 31, 2023 and 2022 is presented in the following table:

 

 

Three Months Ended

 

 

March 31, 2023

 

 

March 31, 2022

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

 

 

 

Grant Date

 

 

Shares

 

 

Fair Value

 

 

Shares

 

 

Fair Value

 

Unvested at beginning of period

 

 

 

 

$

 

 

 

0.2

 

 

$

14.72

 

Transfers to restricted stock units

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

 

 

 

 

 

 

 

 

 

 

Unvested at end of period

 

 

 

 

$

 

 

 

0.2

 

 

$

14.72

 

Schedule of restricted stock unit activity The value of restricted stock units that vest over time is established by the market price on the date of its grant. A summary of the Company’s restricted stock unit activity for the three months ended March 31, 2023 and 2022 is presented in the following table:

 

 

Three Months Ended

 

 

March 31, 2023

March 31, 2022

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

 

 

 

Grant Date

 

 

Shares (000's)

 

 

Fair Value

 

 

Shares (000's)

 

 

Fair Value

 

Unvested at beginning of period

 

 

539

 

 

$

60.73

 

 

 

566

 

 

$

52.66

 

Transfers to restricted stock awards

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

124

 

 

 

103.17

 

 

 

189

 

 

 

74.57

 

Vested

 

 

(157

)

 

 

57.46

 

 

 

(111

)

 

 

51.10

 

Forfeited and cancelled

 

 

(31

)

 

 

63.63

 

 

 

(18

)

 

 

54.88

 

Unvested at end of period

 

 

475

 

 

$

72.67

 

 

 

626

 

 

$

59.50

 

 

Schedule of Stock-based Awards Issued to Non-employee Consultants

A summary of the Company’s PSU activity for the three months ended March 31, 2023 and 2022 is presented in the following table:

 

 

Three Months Ended

 

 

March 31, 2023

March 31, 2022

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

 

 

 

 

 

Grant Date

 

 

Shares (000's)

 

 

Fair Value

 

 

Shares (000's)

 

 

Fair Value

 

Unvested at beginning of period

 

 

76

 

 

$

91.48

 

 

 

15

 

 

$

64.65

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

 

 

 

 

 

 

 

 

 

 

Unvested at end of period

 

 

76

 

 

$

91.48

 

 

 

15

 

 

$

64.65